Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients

We review the current data on epidemiology, the clinical significance, the pathophysiologic mechanisms, and the treatment of VAs in the setting of COVID-19. VAs prevail in 0.15% to 8% of hospitalized patients, but only sustained and rapid tachyarrhythmias are purportedly associated with a significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarantino, Nicola, Della Rocca, Domenico G., Zou, Fengwei, Lin, Aung, Natale, Andrea, Di Biase, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554003/
https://www.ncbi.nlm.nih.gov/pubmed/35221078
http://dx.doi.org/10.1016/j.ccep.2021.10.002
_version_ 1784591698339299328
author Tarantino, Nicola
Della Rocca, Domenico G.
Zou, Fengwei
Lin, Aung
Natale, Andrea
Di Biase, Luigi
author_facet Tarantino, Nicola
Della Rocca, Domenico G.
Zou, Fengwei
Lin, Aung
Natale, Andrea
Di Biase, Luigi
author_sort Tarantino, Nicola
collection PubMed
description We review the current data on epidemiology, the clinical significance, the pathophysiologic mechanisms, and the treatment of VAs in the setting of COVID-19. VAs prevail in 0.15% to 8% of hospitalized patients, but only sustained and rapid tachyarrhythmias are purportedly associated with a significant increase in mortality. Multiple factors can elicit VAs, which are ultimately deemed to be a marker of severe systemic disease rather than a distinct cardiac condition. Even though the electrophysiologist plays a determinant role in the secondary prevention of VAs, a multidisciplinary approach is indispensable for primary prophylaxis and acute management.
format Online
Article
Text
id pubmed-8554003
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85540032021-10-29 Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients Tarantino, Nicola Della Rocca, Domenico G. Zou, Fengwei Lin, Aung Natale, Andrea Di Biase, Luigi Card Electrophysiol Clin Article We review the current data on epidemiology, the clinical significance, the pathophysiologic mechanisms, and the treatment of VAs in the setting of COVID-19. VAs prevail in 0.15% to 8% of hospitalized patients, but only sustained and rapid tachyarrhythmias are purportedly associated with a significant increase in mortality. Multiple factors can elicit VAs, which are ultimately deemed to be a marker of severe systemic disease rather than a distinct cardiac condition. Even though the electrophysiologist plays a determinant role in the secondary prevention of VAs, a multidisciplinary approach is indispensable for primary prophylaxis and acute management. Elsevier Inc. 2022-03 2021-10-29 /pmc/articles/PMC8554003/ /pubmed/35221078 http://dx.doi.org/10.1016/j.ccep.2021.10.002 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Tarantino, Nicola
Della Rocca, Domenico G.
Zou, Fengwei
Lin, Aung
Natale, Andrea
Di Biase, Luigi
Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients
title Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients
title_full Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients
title_fullStr Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients
title_full_unstemmed Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients
title_short Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients
title_sort prevalence, outcomes, and management of ventricular arrhythmias in covid-19 patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554003/
https://www.ncbi.nlm.nih.gov/pubmed/35221078
http://dx.doi.org/10.1016/j.ccep.2021.10.002
work_keys_str_mv AT tarantinonicola prevalenceoutcomesandmanagementofventriculararrhythmiasincovid19patients
AT dellaroccadomenicog prevalenceoutcomesandmanagementofventriculararrhythmiasincovid19patients
AT zoufengwei prevalenceoutcomesandmanagementofventriculararrhythmiasincovid19patients
AT linaung prevalenceoutcomesandmanagementofventriculararrhythmiasincovid19patients
AT nataleandrea prevalenceoutcomesandmanagementofventriculararrhythmiasincovid19patients
AT dibiaseluigi prevalenceoutcomesandmanagementofventriculararrhythmiasincovid19patients

Ejemplares similares